System for real-time monitoring of mutation-in-progress.

about

Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus.Microchip system for monitoring microbial physiological behaviour under drug influences.

P2860

Q42132631-9DDD9EA0-9757-4728-8E90-D439591CF8B1 Q43278659-E94B65ED-7DE5-42C6-8651-F8DA9FD47696

P2860

System for real-time monitoring of mutation-in-progress.

Item

http://www.wikidata.org/entity/Q46734909

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

System for real-time monitoring of mutation-in-progress.

@en

System for real-time monitoring of mutation-in-progress.

@nl

type

Item

label

System for real-time monitoring of mutation-in-progress.

@en

System for real-time monitoring of mutation-in-progress.

@nl

prefLabel

System for real-time monitoring of mutation-in-progress.

@en

System for real-time monitoring of mutation-in-progress.

@nl

P1476

System for real-time monitoring of mutation-in-progress.

@en

P2093

A Sutandar

http://www.w3.org/2001/XMLSchema#string

C S Lim

http://www.w3.org/2001/XMLSchema#string

P2860

New approach for accurate simulation of human pharmacokinetics in an in vitro pharmacodynamic model: application to ciprofloxacin.

Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.

First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America

Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC.

Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.

Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar

Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.

In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance.

P304

1400-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2672.2007.03659.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Li Yang Hsu

P577

2008-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5552879

http://www.w3.org/2001/XMLSchema#string

P698

18298541

http://www.w3.org/2001/XMLSchema#string

System for real-time monitoring of mutation-in-progress.

about

P2860

P2860

System for real-time monitoring of mutation-in-progress.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698